Catalyst Event
Yuhan Corp (000100) · Other
From KRX Bio Technology Transfer Index (KBIOTT)
3/20/2026, 12:00:00 AM
At the Annual General Meeting on Mar 20, 2026, the company approved the FY2025 financial statements and confirmed a year-end cash dividend of KRW 600 per common share.
Korean Translation
2026년 3월 20일 정기주주총회에서 2025년 재무제표를 승인하고 보통주 1주당 600원의 기말 현금배당을 확정함.
Related Recent Events
Hanmi Pharm Co Ltd (128940) · Other
Annual general shareholder meeting on 2026-03-31 to vote on the appointment of a new CEO and board members amid a management dispute; high impact estimated due to potential governance shift scheduled.
3/31/2026, 12:00:00 AM
LigaChem Biosciences Inc (141080) · Other
The 20th Annual General Shareholders' Meeting on March 31, 2026, to approve financial statements and appoint a new director (Low importance estimated as standard annual meetings without major corporate changes usually have minimal price impact) scheduled
3/31/2026, 12:00:00 AM
Daewoong Pharmaceutical Co Ltd (069620) · Other
The 25th Annual General Meeting of Shareholders is scheduled for March 26, 2026. Low importance is estimated as the agenda items are routine and unlikely to cause significant price volatility scheduled.
3/26/2026, 12:00:00 AM
Chong Kun Dang Pharm Co (185750) · Other
The 13th Annual General Meeting of Shareholders is scheduled.
3/26/2026, 12:00:00 AM
Alteogen Inc (196170) · Other
Alteogen's exclusive license agreement with Biogen for its ALT-B4 technology on March 25, 2026, is expected to have a >10% price impact due to the significant deal size of 867.6 billion KRW, scheduled.
3/25/2026, 12:00:00 AM
AprilBio Co Ltd (397030) · Other
The 13th Annual General Meeting of Shareholders was held on March 25, 2026. Resolutions passed included the approval of the 2025 financial statements, amendments to the articles of incorporation, and the granting of stock options.
3/25/2026, 12:00:00 AM